City Therapeutics, Inc (CTY) vs MoonLake Immunotherapeutics (MLTX)

City Therapeutics, Inc CTY 18.56 +8.73%
MoonLake Immunotherapeutics MLTX 11.49 +6.39%

City Therapeutics, Inc and MoonLake Immunotherapeutics are both Biotechnology companies. City Therapeutics, Inc and MoonLake Immunotherapeutics are of similar size ($919.2M and $882.9M).

Metric	CTY	MLTX	Biotechnology median
P/E	—	n/m	10.60
P/S	—	n/m	9.40
P/B	—	1.98	2.13
Price to free cash flow	—	n/m	25.18
EV/EBITDA	—	n/m	0.66
EV/Sales	—	n/m	9.02
Earnings yield	—	(33.42%)	(32.88%)
Free cash flow yield	—	(26.52%)	(23.13%)

Metric	CTY	MLTX	Biotechnology median
Gross margin	—	0.00%	68.51%
Operating margin	—	0.00%	0.00%
Net margin	—	0.00%	0.00%
Free cash flow margin	—	0.00%	0.00%
Return on equity	—	(67.08%)	(51.96%)
Return on assets	—	(51.00%)	(46.06%)
Return on invested capital	—	0.00%	0.00%

Metric	CTY	MLTX	Biotechnology median
Revenue growth (TTM)	—	—	6.76%
EPS growth (last fiscal year)	—	(86.77%)	29.88%
Revenue growth, 5-year CAGR	—	—	9.75%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	CTY	MLTX	Biotechnology median
Debt to equity	—	0.23	0.00
Current ratio	—	12.56	4.97
Net debt to EBITDA	—	1.32	1.01

Metric	CTY	MLTX	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	CTY	MLTX	Biotechnology median
Market cap	882.88m	919.15m	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack